M&A Deal Summary |
|
|---|---|
| Date | 2019-05-22 |
| Target | Sellers Dorsey & Associates |
| Sector | Business Services |
| Buyer(s) | Consonance Capital Partners |
| Deal Type | Recapitalization |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2005 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Consonance Capital Partners is a healthcare-focused private investment firm focused on both public and private equity investing. The Firm's private equity group targets growth equity, leveraged buyouts, and recapitalization transactions in lower middle-market companies with $25 to $500 million of revenue. Specific areas of interest include healthcare providers, mayors, distribution, medical devices, specialty pharmaceuticals, outsourced services, and healthcare IT. Consonance Capital Partners was formed in 2005 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 9 |
| Sector: Business Services M&A | 1 of 1 |
| Type: Recapitalization M&A Deals | 4 of 4 |
| State: Pennsylvania M&A | 2 of 2 |
| Country: United States M&A | 8 of 9 |
| Year: 2019 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-02-06 |
Orsini
Elk Grove Village, Illinois, United States Orsini is a provider of specialty pharmacy services, supplying orphan drugs to patients with rare and complicated diseases that are often life-long such as hereditary angioedema, enzyme replacement therapy, muscular dystrophy, and opioid addiction. These conditions require high touch care coordination services, which are generally provided in the home. Orsini was founded in 1987 and is based in Elk Grove Village, Illinois. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-08-08 |
Corindus Vascular Robotics
Waltham, Massachusetts, United States Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The Company’s CorPath® platform is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. CorPath GRX is the second-generation robotic-assisted technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. We are focused on developing innovative robotic solutions to revolutionize the treatment of emergent conditions by providing specialized and timely medical care to patients around the world. |
Sell | $1.1B |
